MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2018 International Congress

    Screening performance of abbreviated versions of the UPSIT smell test

    T. Joseph, S. Auger, L. Peress, D. Rack, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare the screening performance of existing abbreviated (4-12 item) versions of the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and to identify…
  • 2018 International Congress

    Odor identification in PD patients and controls in Estonian cohort

    I. Kalju, T. Toomsoo, K. Vender (Tallinn, Estonia)

    Objective: To evaluate odors that discriminate Parkinson patients from healthy persons. Background: More than 90% of PD patients are diagnosed with olfactory impairment. The investigation…
  • 2018 International Congress

    Risk estimation in the years preceding diagnosis of Parkinson’s disease in the PREDICT-PD cohort

    S. Auger, D. Rack, J. Bestwick, G. Giovannoni, A. Lees, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To test and refine the use of probability-based algorithms to identify individuals at high-risk of developing Parkinson’s disease (PD). Background: Neurodegeneration preceding a formal…
  • 2018 International Congress

    Olfactory dysfunction predicting cognition

    X. Yu (Cleveland, OH, USA)

    Objective: To investigate the relationship between impairment in smell and cognitive function among older adults using both self-report and objective measurement of olfactory function. Background:…
  • 2018 International Congress

    A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

    T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)

    Objective: The aim of this study is to create mouse models reproducing the course of PD pathology and symptoms. Background: Parkinson's disease (PD) is a…
  • 2018 International Congress

    Olfactory impairment correlates strongly with limbic blood flow in patients with Parkinson’s disease

    K. Ohta, T. Nakajima (Niigata, Japan)

    Objective: To examine the cerebral blood flow pattern of patients of Parkinson's disease with olfactory disorders, and to investigate the correlation between olfactory impairment and…
  • 2017 International Congress

    The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease

    D.-Y. Kwon (Ansan, Republic of Korea)

    Objective: The aim of this study was to investigate the relationship between the degree of olfactory function and motor subtype of Parkinson's disease (PD).  Background:…
  • 2017 International Congress

    Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia

    S.J. Kang, J.Y. Ahn, H.-T. Kim (Seoul, Republic of Korea)

    Objective: To investigate the differences of olfactory dysfunction in patients within SWEDDs  Background: The concept of SWEDD(scans without evidence of dopaminergic deficit) originates from the clinical…
  • 2017 International Congress

    Motor performance measured with the UPDRS in PD patientswith varying degrees of smell loss

    c. cox, A. Kahttab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To establish whether there is a possible link between the motor symptoms, which includes RBD in PD patients in this study, who have mild/moderate…
  • 2017 International Congress

    Non-motor symptoms in a cross section of PD patients with varying degrees of smell loss

    c. cox, A. Khattab, K. Amar (Bournemouth. Dorset, United Kingdom)

    Objective: To establish whether patients with PD who have mild/moderate microsmia, severe microsmia or anosmia (as measured by the University of Pennsylvania Smell Identification Test…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Kratom withdrawal induced orobuccal dyskinesia
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley